The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 166K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burns, J. M.
Right arrow Articles by Lewis, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burns, J. M.
Right arrow Articles by Lewis, G. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/11/1917/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 10, November 16, 1998 1917-1927


Articles

A New Monoclonal Antibody, mAb 4A12, Identifies a Role for the Glycosaminoglycan (GAG) Binding Domain of RANTES in the Antiviral Effect against HIV-1 and Intracellular Ca2+ Signaling

Jennifer M. Burns, Robert C. Gallo, Anthony L. DeVico, and George K. Lewis

From the Divisions of Basic Science and Vaccine Research, Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, Maryland 21201; and the Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland 21201

The β-chemokine RANTES (regulated on activation, normal T cell expressed and secreted) suppresses the infection of susceptible host cells by macrophage tropic strains of HIV-1. This effect is attributed to interactions of this chemokine with a 7-transmembrane domain receptor, CCR5, that is required for virus–cell fusion and entry. Here we identify domains of RANTES that contribute to its biological activities through structure–function studies using a new monoclonal antibody, mAb 4A12, isolated from mice immunized with recombinant human RANTES. This monoclonal antibody (mAb) blocked the antiviral activity of RANTES in infectivity assays with HIV-1Bal, and inhibited the mobilization of intracellular Ca2+ elicited by RANTES, yet recognized this chemokine bound to cell surfaces. Epitope mapping using limited proteolysis, reversed phase high-performance liquid chromatography, and mass spectrometry suggest that residues 55–66 of RANTES, which include the COOH-terminal {alpha}-helical region implicated as the glycosaminoglycan (GAG) binding domain, overlap the determinant recognized by mAb 4A12. This is supported by affinity chromatography studies, which showed that RANTES could be eluted specifically by heparin from a mAb 4A12 immunoaffinity matrix. Removal of cell surface GAGs by enzymatic digestion greatly reduced the ability of mAb 4A12 to detect RANTES passively bound on cell surfaces and abrogated the ability of RANTES to elicit an intracellular Ca2+ signal. Taken together, these studies demonstrate that the COOH-terminal {alpha}-helical region of RANTES plays a key role in GAG-binding, antiviral activity, and intracellular Ca2+ signaling and support a model in which GAGs play a key role in the biological activities of this chemokine.

Key Words: β-chemokines • human immunodeficiency virus 1 • monoclonal antibody • signaling • antiviral effect


Address correspondence to Anthony L. DeVico or George K. Lewis, Institute of Human Virology, 725 W. Lombard St., Baltimore, MD 21201. Phone: 410-706-4688; Fax: 410-706-4695; E-mail: devico @umbi.umd.edu or lewisg{at}umbi.umd.edu

The skillful technical assistance of Mr. Robert Tuskan and Ms. Beverly Lamb is genuinely appreciated. We thank Dr. Roberta Kamin-Lewis for critical comments. We thank Dr. K. Swiderek, Beckman Research Institute of the City of Hope, City of Hope, CA for sequence analysis.

A.L. DeVico and G.K. Lewis contributed equally to this work.

This work was submitted by J.M. Burns in partial fulfillment of the requirements of a Ph.D. thesis in the Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201.

Abbreviations used: FBS, fetal bovine serum; GAG, glycosaminoglycan; MIP, macrophage inflammatory protein; RANTES, regulated on activation, normal T cell expressed and secreted; TCID50, tissue culture dose that infects 50% of cultures.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS